SETTING: Multidrug-resistant tuberculosis (MDR-TB) treatment facility, Orel Oblast, Russian Federation. OBJECTIVES: To determine factors associated with poor outcome and to document status of patients after recording of TB outcomes. DESIGN: Retrospective review of prospective single cohort. RESULTS: Among 192 patients, factors significantly associated with poor outcome in multivariate analysis include three or more treatment interruptions during the intensive phase of therapy and alcohol or drug addiction (adjusted OR [aOR] 2.1, 95%CI 1.0-4.3 and aOR 1.9, 95%CI 1.0-3.7). Previous treatment was associated with poor outcome, but only among smear-positive patients (aOR 3.1, 95%CI 1.3-7.3). Ten patients (5%) developed extensively drug-resistant TB (XDR-TB) during treatment; of 115 patients with at least 6 months of follow-up data after outcomes were recorded, 13 (11%) developed XDR-TB. CONCLUSION: Interventions focused on supporting patient adherence during the intensive phase of treatment; the management of drug and alcohol addiction should be developed and studied. A substantial proportion of patients developed XDR-TB during and after treatment. Longer term follow-up data of patients treated for MDR-TB are needed to better inform programmatic policy.
SETTING: Multidrug-resistant tuberculosis (MDR-TB) treatment facility, Orel Oblast, Russian Federation. OBJECTIVES: To determine factors associated with poor outcome and to document status of patients after recording of TB outcomes. DESIGN: Retrospective review of prospective single cohort. RESULTS: Among 192 patients, factors significantly associated with poor outcome in multivariate analysis include three or more treatment interruptions during the intensive phase of therapy and alcohol or drug addiction (adjusted OR [aOR] 2.1, 95%CI 1.0-4.3 and aOR 1.9, 95%CI 1.0-3.7). Previous treatment was associated with poor outcome, but only among smear-positive patients (aOR 3.1, 95%CI 1.3-7.3). Ten patients (5%) developed extensively drug-resistant TB (XDR-TB) during treatment; of 115 patients with at least 6 months of follow-up data after outcomes were recorded, 13 (11%) developed XDR-TB. CONCLUSION: Interventions focused on supporting patient adherence during the intensive phase of treatment; the management of drug and alcohol addiction should be developed and studied. A substantial proportion of patients developed XDR-TB during and after treatment. Longer term follow-up data of patients treated for MDR-TB are needed to better inform programmatic policy.
Authors: E Nathanson; R Gupta; P Huamani; V Leimane; A D Pasechnikov; T E Tupasi; K Vink; E Jaramillo; M A Espinal Journal: Int J Tuberc Lung Dis Date: 2004-11 Impact factor: 2.373
Authors: S S Shin; A D Pasechnikov; I Y Gelmanova; G G Peremitin; A K Strelis; S Mishustin; A Barnashov; Y Karpeichik; Y G Andreev; V T Golubchikova; T P Tonkel; G V Yanova; M Nikiforov; A Yedilbayev; J S Mukherjee; J J Furin; D J Barry; P E Farmer; M L Rich; S Keshavjee Journal: Int J Tuberc Lung Dis Date: 2006-04 Impact factor: 2.373
Authors: W M Jakubowiak; E M Bogorodskaya; S E Borisov; E S Borisov; I D Danilova; D I Danilova; E V Kourbatova; E K Kourbatova Journal: Int J Tuberc Lung Dis Date: 2007-01 Impact factor: 2.373
Authors: Vaira Leimane; Vija Riekstina; Timothy H Holtz; Evija Zarovska; Vija Skripconoka; Lorna E Thorpe; Kayla F Laserson; Charles D Wells Journal: Lancet Date: 2005 Jan 22-28 Impact factor: 79.321
Authors: M F Fleming; E Krupitsky; M Tsoy; E Zvartau; N Brazhenko; W Jakubowiak; M E McCaul Journal: Int J Tuberc Lung Dis Date: 2006-05 Impact factor: 2.373
Authors: Sonya S Shin; Salmaan Keshavjee; Irina Y Gelmanova; Sidney Atwood; Molly F Franke; Sergey P Mishustin; Aivar K Strelis; Yevgeny G Andreev; Alexander D Pasechnikov; Alexander Barnashov; Tamara P Tonkel; Ted Cohen Journal: Am J Respir Crit Care Med Date: 2010-04-22 Impact factor: 21.405
Authors: Edward D Chan; Valerie Laurel; Matthew J Strand; Julanie F Chan; Mai-Lan N Huynh; Marian Goble; Michael D Iseman Journal: Am J Respir Crit Care Med Date: 2004-01-23 Impact factor: 21.405
Authors: Eva Nathanson; Catharina Lambregts-van Weezenbeek; Michael L Rich; Rajesh Gupta; Jaime Bayona; Kai Blöndal; José A Caminero; J Peter Cegielski; Manfred Danilovits; Marcos A Espinal; Vahur Hollo; Ernesto Jaramillo; Vaira Leimane; Carole D Mitnick; Joia S Mukherjee; Paul Nunn; Alexander Pasechnikov; Thelma Tupasi; Charles Wells; Mario C Raviglione Journal: Emerg Infect Dis Date: 2006-09 Impact factor: 6.883
Authors: J Peter Cegielski; Ekaterina Kurbatova; Martie van der Walt; Jeannette Brand; Julia Ershova; Thelma Tupasi; Janice Campos Caoili; Tracy Dalton; Carmen Contreras; Martin Yagui; Jaime Bayona; Charlotte Kvasnovsky; Vaira Leimane; Liga Kuksa; Michael P Chen; Laura E Via; Soo Hee Hwang; Melanie Wolfgang; Grigory V Volchenkov; Tatiana Somova; Sarah E Smith; Somsak Akksilp; Wanpen Wattanaamornkiet; Hee Jin Kim; Chang-Ki Kim; Boris Y Kazennyy; Tatiana Khorosheva; Kai Kliiman; Piret Viiklepp; Ruwen Jou; Angela Song-En Huang; Irina A Vasilyeva; Olga V Demikhova; Joey Lancaster; Ronel Odendaal; Lois Diem; Therese C Perez; Tarcela Gler; Kathrine Tan; Cesar Bonilla; Oswaldo Jave; Luis Asencios; Gloria Yale; Carmen Suarez; Allison Taylor Walker; Inga Norvaisha; Girts Skenders; Ingrida Sture; Vija Riekstina; Andra Cirule; Erika Sigman; Sang-Nae Cho; Ying Cai; Seokyong Eum; Jongseok Lee; Seungkyu Park; Doosoo Jeon; Isdore C Shamputa; Beverly Metchock; Tatiana Kuznetsova; Rattanawadee Akksilp; Wanlaya Sitti; Jirapan Inyapong; Elena V Kiryanova; Irina Degtyareva; Evgenia S Nemtsova; Klavdia Levina; Manfred Danilovits; Tiina Kummik; Yung-Chao Lei; Wei-Lun Huang; Vladislav V Erokhin; Larisa N Chernousova; Sofia N Andreevskaya; Elena E Larionova; Tatyana G Smirnova Journal: Clin Infect Dis Date: 2015-10-27 Impact factor: 9.079
Authors: Kalpita S Shringarpure; Petros Isaakidis; Karuna D Sagili; R K Baxi; Mrinalini Das; Amrita Daftary Journal: PLoS One Date: 2016-03-09 Impact factor: 3.240